Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesHematopoietic Stem Cell TransplantationAnemia, AplasticHematopoietic Stem CellsTransplantation ConditioningLeukemiaLiver TransplantationTransplantation ChimeraGraft SurvivalTissue DonorsBone Marrow PurgingBusulfanHistocompatibility TestingHematopoiesisCyclophosphamideHistocompatibilityMice, Inbred C57BLTransplantation, IsogeneicBone Marrow DiseasesCombined Modality TherapyKidney TransplantationRecurrenceCell DifferentiationStem CellsTime FactorsRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteColony-Forming Units AssayTreatment OutcomeBone Marrow ExaminationStem Cell TransplantationHematologic NeoplasmsRemission InductionImmunosuppressive AgentsPrecursor Cell Lymphoblastic Leukemia-LymphomaGraft RejectionBone RemodelingHepatic Veno-Occlusive DiseaseBone Marrow NeoplasmsLeukemia, MyeloidSurvival AnalysisCell ProliferationTransplantation ImmunologyFlow CytometryGraft vs Host ReactionLymphoma, Non-HodgkinRetrospective StudiesLymphocyte DepletionImmunosuppressionAntineoplastic Combined Chemotherapy ProtocolsAcute DiseaseT-LymphocytesLeukocyte TransfusionHeart TransplantationCells, CulturedAntigens, CD34ChimeraSevere Combined ImmunodeficiencyMyelodysplastic SyndromesMice, Inbred BALB CSurvival RateHLA AntigensBreast NeoplasmsFollow-Up StudiesLung TransplantationHematologic DiseasesActuarial AnalysisGranulocyte Colony-Stimulating FactorCyclosporineAntineoplastic AgentsBone DensityCell LineageCell DivisionLymphocyte TransfusionDisease-Free SurvivalApoptosisNeoplasmsPrognosisCarmustineNuclear FamilyMice, KnockoutPancytopeniaCell SurvivalLeukocyte CountEtoposideSpleenCell MovementOrgan TransplantationCytarabineCell SeparationGraft vs Tumor EffectCell Line, Tumor